# Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

> **NCT00989274** · PHASE2 · WITHDRAWN · sponsor: **Instituto Nacional de Salud Publica, Mexico**

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Vaccine Sanofi A(H1N1) 15 ug & trivalent
- **BIOLOGICAL:** Vaccine Sanofi (H1N1) 15 ug.nonadyuvante
- **BIOLOGICAL:** Vaccine Sanofi A(H1N1) 7.5 ug

## Key facts

- **NCT ID:** NCT00989274
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Late approval by the Secretariat of Health, and expiration of vaccine
- **Last updated:** 2012-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989274, "Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00989274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*